Edition:
United Kingdom

Array Biopharma Inc (ARRY.OQ)

ARRY.OQ on NASDAQ Stock Exchange Global Market

25.71USD
4:37pm BST
Change (% chg)

$-0.06 (-0.23%)
Prev Close
$25.77
Open
$25.95
Day's High
$26.17
Day's Low
$25.33
Volume
646,485
Avg. Vol
934,359
52-wk High
$26.82
52-wk Low
$12.58

About

Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. The Company's programs include approximately three cancer drugs, binimetinib, encorafenib and selumetinib (partnered with AstraZeneca, PLC). Its... (more)

Overall

Beta: 1.99
Market Cap(Mil.): $2,368.37
Shares Outstanding(Mil.): 192.24
Dividend: --
Yield (%): --

Financials

  ARRY.OQ Industry Sector
P/E (TTM): -- 69.30 32.55
EPS (TTM): -0.72 -- --
ROI: -71.65 8.91 13.82
ROE: -- 10.05 15.24

Array BioPharma's colorectal cancer combo treatment meets main goals

Array BioPharma Inc's cocktail of three therapies helped patients with a type of colorectal cancer live longer than those on standard treatment, according to interim results of a late-stage study on Tuesday.

21 May 2019

Array BioPharma's colorectal cancer combo treatment meets main goals

May 21 Array BioPharma Inc's cocktail of three therapies helped patients with a type of colorectal cancer live longer than those on standard treatment, according to interim results of a late-stage study on Tuesday.

21 May 2019

Earnings vs. Estimates